These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23621932)

  • 21. HIV-1 mother-to-child transmission, post-test counselling, and antiretroviral prophylaxis in Northern Viet Nam: a prospective observational study.
    Ha TT; Anh NM; Bao NH; Tuan PL; Caridha R; Gaseitsiwe S; Hien NT; Cam PD; Ehrnst A
    Scand J Infect Dis; 2012 Nov; 44(11):866-73. PubMed ID: 22803820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The incidence and prevalence of AIDS and prevalence of other severe HIV disease in England and Wales for 1995 to 1999: projections using data to the end of 1994.
    Commun Dis Rep CDR Rev; 1996 Jan; 6(1):R1-21. PubMed ID: 8581117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thirty years of HIV and AIDS: future challenges and opportunities.
    Dieffenbach CW; Fauci AS
    Ann Intern Med; 2011 Jun; 154(11):766-71. PubMed ID: 21628350
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimal interference: A basis for selecting ART for prevention with positives.
    Lebouché B; Engler K; Lévy JJ; Gilmore N; Spire B; Rozenbaum W; Routy JP
    AIDS Care; 2013; 25(10):1284-90. PubMed ID: 23394079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomedical strategies for human immunodeficiency virus (HIV) prevention? A new paradigm.
    Chan R
    Ann Acad Med Singap; 2012 Dec; 41(12):595-601. PubMed ID: 23303118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of vitamins, including vitamin A, on HIV/AIDS patients.
    Mehta S; Fawzi W
    Vitam Horm; 2007; 75():355-83. PubMed ID: 17368322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reaping the prevention benefits of highly active antiretroviral treatment: policy implications of HIV Prevention Trials Network 052.
    Forsyth AD; Valdiserri RO
    Curr Opin HIV AIDS; 2012 Mar; 7(2):111-6. PubMed ID: 22227586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia.
    Poynten IM; Jin F; Prestage GP; Kaldor JM; Imrie J; Grulich AE
    HIV Med; 2010 Apr; 11(4):282-8. PubMed ID: 20015220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment as Prevention for HIV Infection: Current Data, Challenges, and Global Perspectives.
    Yombi JC; Mertes H
    AIDS Rev; 2018; 20(3):131-140. PubMed ID: 30264827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surfactants as agents for the individual prevention of HIV/AIDS].
    Krivorutchenko IuL
    Mikrobiol Z; 1999; 61(1):95-103. PubMed ID: 10330875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [HIV/AIDS: the new therapeutic strategies remain a priority].
    Barré-Sinoussi F
    Rev Med Suisse; 2009 Nov; 5(225):2301-2. PubMed ID: 19999324
    [No Abstract]   [Full Text] [Related]  

  • 32. Microbicides-emerging essential pillars of comprehensive HIV/AIDS prevention.
    Gaym A
    Ethiop Med J; 2006 Oct; 44(4):405-15. PubMed ID: 17370443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pre-exposure prophylaxis in HIV--a vision or soon a reality?].
    Reuter S; Meyer D; Knechten H; Oette M; Mitrenga D; Rockstroh J; Fätkenheuer G; Häussinger D
    Dtsch Med Wochenschr; 2009 Dec; 134(50):2582-4. PubMed ID: 19998229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-retrovirals for treatment and prevention--time for new paradigms in our response to the HIV/AIDS epidemic?
    Abdool Karim Q; Bayer R
    Dev World Bioeth; 2013 Aug; 13(2):ii-iii. PubMed ID: 23865982
    [No Abstract]   [Full Text] [Related]  

  • 35. HIV in India--the challenges ahead.
    Steinbrook R
    N Engl J Med; 2007 Mar; 356(12):1197-201. PubMed ID: 17377154
    [No Abstract]   [Full Text] [Related]  

  • 36. Ethical use of antiretroviral resources for HIV prevention in resource poor settings.
    Rennie S
    Dev World Bioeth; 2013 Aug; 13(2):79-86. PubMed ID: 23724978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ARV-based HIV prevention for women - where we are in 2014.
    Mastro TD; Sista N; Abdool-Karim Q
    J Int AIDS Soc; 2014; 17(3 Suppl 2):19154. PubMed ID: 25224614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiretroviral therapy as HIV prevention: status and prospects.
    Mayer KH; Venkatesh KK
    Am J Public Health; 2010 Oct; 100(10):1867-76. PubMed ID: 20724682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health and budget impact of combined HIV prevention - first results of the BELHIVPREV model.
    Vermeersch S; Callens S; De Wit S; Goffard JC; Laga M; Van Beckhoven D; Annemans L
    Acta Clin Belg; 2018 Feb; 73(1):54-67. PubMed ID: 28673201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Turning the tide against AIDS by preventing new HIV infections initial experience with Minnesota's first PrEP clinic.
    Eccles-Radtke C; Henry K
    Minn Med; 2015 Jan; 98(1):45-8. PubMed ID: 25665269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.